Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 106-114

  Zelle, D M ^a   Corpeleijn, E ^a   Van Ree, R M ^a   Stolk, R P ^a   Van Der Veer, E ^a   Gans, R O B ^a   Homan Van Der Heide, J J ^a,b   Navis, G ^a   Bakker, S J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cardiovascular risk factors; Fatty liver disease; Mortality; Renal transplant patients

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; COHORT STUDIES; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 72549109690     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02876.x     Document Type: Article

References (37)

1. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006 82 : 603 611.
2. Diaz JM, Sainz Z, Guirado LL et al. Risk factors for cardiovascular disease after renal transplantation. Transplant Proc 2003 35 : 1722 1724.
3. Hjelmesaeth J, Hartmann A, Midtvedt K et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001 16 : 1047 1052.
4. Kotronen A, Yki-Jarvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008 28 : 27 38.
5. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002 123 : 1705 1725.
6. Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006 91 : 4753 4761.
7. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008 134 : 1682 1698.
8. Westerbacka J, Corner A, Tiikkainen M et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: Implications for sex differences in markers of cardiovascular risk. Diabetologia 2004 47 : 1360 1369.
9. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: The British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009 32 : 741 750.
10. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol 2002 17 : 1136 1143.
11. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006 22 : 437 443.
12. Edens MA, Kuipers F, Stolk RP. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obes Rev 2009 10 : 412 419.
13. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001 38 : 263 355.
14. Tahan V, Canbakan B, Balci H et al. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 2008 55 : 1433 1438.
15. Lee DH, Ha MH, Kim JH et al. Gamma-glutamyltransferase and diabetes - A 4 year follow-up study. Diabetologia 2003 46 : 359 364.
16. Lee DH, Jacobs DR Jr., Gross M et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003 49 : 1358 1366. (Pubitemid 36900623)
17. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: Analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007 27 : 2729 2735.
18. Wannamethee SG, Lennon L, Shaper AG. The value of gamma- glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008 201 : 168 175.
19. Lee DS, Evans JC, Robins SJ et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007 27 : 127 133.
20. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000 248 : 230 238.
21. Kang YH, Min HK, Son SM, Kim IJ, Kim YK. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract 2007 77 : 306 313.
22. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001 50 : 1844 1850.
23. Regidor DL, Kovesdy CP, Mehrotra R et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 2008 19 : 2193 2203.
24. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr., Haffner SM. Liver markers and development of the metabolic syndrome: The insulin resistance atherosclerosis study. Diabetes 2005 54 : 3140 3147.
25. van Ree RM, de Vries AP, Oterdoom LH et al. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. Nephrol Dial Transplant 2005 20 : 2524 2531.
26. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008 31 (Suppl 1 S55 S60.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
28. de Leeuw K, Sanders JS, Stegeman C, Smit A, Kallenberg CG, Bijl M. Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 2005 64 : 753 759. (Pubitemid 40559304)
29. Schiele F, Henny J, Hitz J, Petitclerc C, Gueguen R, Siest G. Total bone and liver alkaline phosphatases in plasma: Biological variations and reference limits. Clin Chem 1983 29 : 634 641.
30. Ali AT, Paiker JE, Crowther NJ. The relationship between anthropometry and serum concentrations of alkaline phosphatase isoenzymes, liver-enzymes, albumin, and bilirubin. Am J Clin Pathol 2006 126 : 437 442.
31. Anonymous. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 106 : 3143 3421.
32. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 : 3066 3072.
33. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000 152 : 897 907.
34. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004 38 : 535 539.
35. Paolicchi A, Emdin M, Ghliozeni E et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004 109 : 1440.
36. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: Triggering oxidative stress within the plaque. Circulation 2005 112 : 2078 2080.
37. Bakker SJ, IJzerman RG, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity: The missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 2000 148 : 17 21.